Nicolas Rabasso

Nicolas Rabasso

Auto-generated profile, based on publicly available information

Nicolas Rabasso

Méthodologie Synthèse et Molécules Thérapeutiques Université Paris-Saclay CNRS Institut de chimie moléculaire et des matériaux d'Orsay 91405 Orsay France

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2011 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
AFAntoine Fadel
Antoine Fadel
FLFrédéric Legrand
Frédéric Legrand
GEGwilherm Evano
Gwilherm Evano
NRNicolas Rabasso
Nicolas Rabasso

1 August 2003 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
FCFrançois Couty
François Couty
GEGwilherm Evano
Gwilherm Evano
NRNicolas Rabasso
Nicolas Rabasso

1 January 2005 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
HBHans Bräuner-Osborne
Hans Bräuner-Osborne
LBLennart Bunch
Lennart Bunch
NCNathalie Chopin
Nathalie Chopin
FCFrançois Couty
François Couty
GEGwilherm Evano
Gwilherm Evano
NRNicolas Rabasso
Nicolas Rabasso
A set of ten azetidinic amino acids, that can be envisioned as C-4 alkyl substituted analogues of trans-2-carboxyazetidine-3-acetic acid (t-CAA) and/or conformationally constrained analogues of (R)- or (S)-glutamic acid (Glu) have been synthesized in a diastereo- and enantiomerically pure form from β-amino alcohols through a straightforward five step sequence. The key step of this synthesis is an original anionic 4-exo-tet ring closure that forms the azetidine ring upon an intramolecular Michael addition. This reaction was proven to be reversible and to lead to a thermodynamic distribution of two diastereoisomers that were easily separated and converted in two steps into azetidinic amino acids. Azetidines 35–44 were characterized in binding studies on native ionotropic Glu receptors and in functional assays at cloned metabotropic receptors mGluR1, 2 and 4, representing group I, II and III mGlu receptors, respectively. Furthermore, azetidine analogues 35, 36 and 40 were also characterized as potential ligands at the glutamate transporter subtypes EAAT1–3 in the FLIPR® Membrane Potential (FMP) assay. The (2R)-azetidines 35, 37, 39, 41 and 43 were inactive in iGlu, mGlu and EAAT assays, whereas a marked change in the pharmacological profile at the iGlu receptors was observed when a methyl group was introduced in the C-4 position, compound 36versust-CAA. At EAAT1–3, compound 35 was inactive, whereas azetidines 36 and 40 were both identified as inhibitors and showed selectivity for the EAAT2 subtype.

1 January 2010 in Tetrahedron Letters
Verified
Journal Article
Closed access
NRNicolas Rabasso
Nicolas Rabasso
AFAntoine Fadel
Antoine Fadel

29 May 2000 in Tetrahedron Letters
Verified
Journal Article
Closed access
CAClaude Agami
Claude Agami
FCFrançois Couty
François Couty
NRNicolas Rabasso
Nicolas Rabasso